Method for the Treatment or Prevention of Cardiac Hypertrophy
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Jun 26, 2008
app pub date -
May 12, 2005
filing date -
May 12, 2004
priority date (Note) -
Abandoned
status (Latency Note)
Importance
Loading Importance Indicators... 
Abstract
A method for the treatment or prevention of cardiac hypertrophy or diastolic heart failure resulting from cardiac hypertrophy by administering levosimendan or its metabolite (II) or any of their pharmaceutically acceptable salts to a mammal in need of such treatment.
Loading the Abstract Image...
OK
First Claim
Family
Loading Family data...
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully